ARCHIVE

• WEBSITE NEWS
  March 3, 2003

• Meet the Leaders (16)
  March 3, 2003

• Takeda Discovers Novel Mechanism of Insulin Secretion
  March 3, 2003

• Fujisawa Licenses GPCR Drug Target from TaiGen
  March 3, 2003

• Shionogi Expects Sharp Recovery from FY2003
  March 3, 2003

• Kaken to Codevelop Antifungals with Elitra of the US
  March 3, 2003

• NBI's AII Receptor Antagonist Micardis Off to Strong Start
  March 3, 2003

• Global CRO Market Grew to US$7 Billion in 2001: 6th Nomura Bioconference
  March 3, 2003

• Dainippon Introduces New System to Boost R&D Efficiency
  March 3, 2003

• PERSS SEMINAR
  March 3, 2003

• Santen's New Mid-term Plan Focuses on Profits, Stronger R&D
  March 3, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  March 3, 2003

• Prices Settled for 96% of Customers by Year-end: Suzuken
  March 3, 2003

• Anthelios XL Sunscreen to Protect against UV Radiation: L'oreal Seminar
  March 3, 2003

• End-of-year Price Agreement Rate Up 15-20% vs FY2000: Azwell
  March 3, 2003

• DIAGNOSTIC NEWS IN BRIEF
  March 3, 2003

• Intellectual Property Rights Must Be Considered Together with NHI Price System: FPMAJ President
  March 3, 2003

• Mr Fujii Calls For Promotion of OTC Drugs, Expansion of Pharmacists' Role
  March 3, 2003

• FPMAJ, PMAT, OPMA to Undertake Reorganization from FY2003
  March 3, 2003

• Matsumotokiyoshi Embarks on Sale of Nursing Care Products
  March 3, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 614
• 615
• 616
• 617
• 618
• 619
• 620
• 621
• 622
• …
• Next ›
• 最終 »